user

EUTOS Score Is Not Predictive for Survival and Outcome in Patients (pts) with Chronic Myeloid Leukemia in Early Chronic Phase (CML-CP) Treated with Tyrosine Kinase Inhibitors (TKIs) At MD Anderson Cancer Center (MDACC)

被引：0
|
作者：
Nazha, Aziz [1 ]
Jabbour, Elias [1 ]
Cortes, Jorge E. [1 ]
O'Brien, Susan [1 ]
Shan, Jenny [1 ]
Garcia-Manero, Guillermo [1 ]
Quintas-Cardama, Alfonso [1 ]
Kantarjian, Hagop M. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1609 / 1609
页数：1
相关论文
共 50 条
  • [1] EUTOS score is not predictive for survival and outcome in patients with early chronic phase chronic myeloid leukemia treated with tyrosine kinase inhibitors: a single institution experience
    Jabbour, Elias
    Cortes, Jorge
    Nazha, Aziz
    O'Brien, Susan
    Quintas-Cardama, Alfonso
    Pierce, Sherry
    Garcia-Manero, Guillermo
    Kantarjian, Hagop
    BLOOD, 2012, 119 (19) : 4524 - 4526
  • [2] The Achievement of An Early Complete Cytogenetic Response (CCyR) Is A Major Determinant for Outcome In Patients (pts) with Early Chronic Phase (CP) Chronic Myeloid Leukemia (CML) Treated with Tyrosine Kinase Inhibitors (TKIs)
    Jabbour, Elias
    Kantarjian, Hagop M.
    Shan, Jenny
    O'Brien, Susan
    Kadia, Tapan
    Borthakur, Gautam
    Quintas-Cardama, Alfonso
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Cortes, Jorge
    BLOOD, 2010, 116 (21) : 1405 - 1405
  • [3] APPLICATION OF THE EUTOS SCORE IN A SERIES OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) IN CHRONIC PHASE (CP) TREATED WITH TYROSIN KINASE INHIBITORS (TKI)
    Xicoy, B.
    Boque, C.
    Fernandez, C.
    Vallansot, R.
    Cortes, M.
    Ortin, X.
    Rodriguez, L.
    Plensa, E.
    Buch, J.
    Marce, S.
    Garcia, O.
    Velez, P.
    Abenoza, L.
    Miguel, L.
    de Sevilla, A.
    Grau, J.
    Estrada, N.
    Ribera, J.
    HAEMATOLOGICA, 2013, 98 : 552 - 552
  • [4] Predictive Factors for Response and Outcome in Patients (pts) Treated with Second Generation Tyrosine Kinase Inhibitors (2-TKI) for Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Post Imatinib Failure
    Jabbour, Elias
    Kantarjian, Hagop
    O'Brien, Susan
    Shan, Jenny
    Garcia-Manero, Guillermo
    Wierda, William
    Ravandi, Farhad
    Borthakur, Gautam
    Rios, Mary Beth
    Cortes, Jorge
    BLOOD, 2009, 114 (22) : 210 - 211
  • [5] Does platelet aggregation differ among chronic myeloid leukemia-chronic phase (CML-CP) patients on tyrosine kinase inhibitors (TKIs)? A tertiary center experience
    Moeen, Sawsan M.
    Afifi, Ola A.
    Thabet, Ahmad F.
    Saleh, Medhat A.
    Morad, Mohamed A.
    EGYPTIAN JOURNAL OF HAEMATOLOGY, 2023, 48 (02): : 185 - 190
  • [6] Outcome after Discontinuation of Second Generation Tyrosine Kinase Inhibitors (TKIs) Used As Frontline Therapy for Patients (pts) with Chronic Phase (CP) Chronic Myeloid Leukemia (CML)
    Abdelall, Waleed
    Kantarjian, Hagop M.
    Devendra, K. C.
    Akosile, Mary
    Borthakur, Gautam
    Verstovsek, Srdan
    Daver, Naval
    Pemmaraju, Naveen
    Naqvi, Kiran
    Garcia-Manero, Guillermo
    Thompson, Philip A.
    Ferrajoli, Alessandra
    Ravandi, Farhad
    Konopleva, Marina
    DiNardo, Courtney D.
    Jabbour, Elias J.
    Cortes, Jorge E.
    BLOOD, 2017, 130
  • [7] Effectiveness of Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) after Two or More Prior Tyrosine Kinase Inhibitors
    Dahlen, Torsten
    Kockerols, Camille C. B.
    Ferreira, Germano
    Westerweel, Peter E.
    Mayer, Jiri
    Allepuz, Alex
    Wormser, David
    Yau, Lillian
    Zackova, Daniela
    BLOOD, 2022, 140 : 3889 - 3890
  • [8] Dynamics of Response and Response Factors in Patients (Pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) after ≥2 Prior Tyrosine Kinase Inhibitors (TKIs) in the Phase 3 Ascembl Study
    Hughes, Timothy
    Rea, Delphine
    Boquimpani, Carla
    Minami, Yosuke
    Mauro, Michael
    Cortes, Jorge E.
    Apperley, Jane F.
    Gutierrez, Valentin Garcia
    Kapoor, Shruti
    Allepuz, Alex
    Quenet, Sarah
    Zhang, Yifan
    Hochhaus, Andreas
    BLOOD, 2022, 140 : 6757 - 6759
  • [9] The EUTOS Score Is Highly Predictive for Clinical Outcome and Survival in Asian Patients with Early Chronic Phase Chronic Myeloid Leukemia Treated with Imatinib
    Than, Hein
    Kuan, Lingyee
    Seow, Chiu Hong
    Li, Wenyun
    Allen, John C., Jr.
    Chuah, Charles
    BLOOD, 2012, 120 (21)
  • [10] EUTOS SCORE IS PREDICTIVE FOR SURVIVAL AND OUTCOME IN PATIENTS WITH EARLY CHRONIC PHASE CHRONIC MYELOID LEUKEMIA TREATED WITH NILOTINIB-BASED REGIMENS
    Castagnetti, F.
    Gugliotta, G.
    Palandri, F.
    Breccia, M.
    Levato, L.
    Stagno, F.
    Specchia, G.
    Cambrin, G. Rege
    Luciano, L.
    Gozzini, A.
    Martino, B.
    Capucci, A.
    Intermesoli, T.
    Tiribelli, M.
    Cedrone, M.
    Cavazzini, F.
    Usala, E.
    Soverini, S.
    Testoni, N.
    Pane, F.
    Saglio, G.
    Alimena, G.
    Martinelli, G.
    Rosti, G.
    Baccarani, M.
    HAEMATOLOGICA, 2012, 97 : 76 - 77
12345